XXII: SEC Form 8-K filed by 22nd Century Group Inc.
Stocks in this Quantisnow insightHealth Care
Full content unavailable. See the original source below.
Historical context for XXII
Across the 30 sessions after earlier XXII headlines, the stock closed higher 7 times and lower 23 times, with a median move of 6.3% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | XXII | SPY |
|---|---|---|---|
| Oct 26, 2026 | 22nd Century Expands the Pinnacle Pure Portfolio To 6 SKU’s With Addition of 100’s and Menthol Varieties | -55.3% | +0.7% |
| Oct 22, 2026 | 22nd Century Group Preliminarily Reports Third Quarter Financial Results | -21.0% | -1.2% |
| Oct 16, 2026 | 22nd Century Same Store Unit Sales for Pinnacle VLN® and Pinnacle Pure Surge 161% | -46.6% | -1.1% |
| Sep 28, 2026 | 22nd Century Group's Reduced-Nicotine Tobacco Platform Positioned to Support France's Nicotine-Reduction Initiative | -28.2% | -0.7% |
| Sep 25, 2026 | 22nd Century Group Urges Policymakers and FDA to Enact and Implement the Reduced Nicotine Content Standard, Citing Years Without a Final Rule | -11.9% | +0.5% |
| Sep 1, 2026 | 22nd Century CEO & Chairman Larry Firestone: Improved Gross Margin, ~5,000 Retail Outlets and >$50B Market Opportunity Highlight Mid-Year Stockholder Letter | -18.4% | -0.7% |
Quantisnow market dataNASDAQ
XXII
22nd Century Group Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
Get push alerts for XXII
Full XXII profile on Quantisnow Follow XXII and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time